Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T16:08:35.622Z.
Consensus retrieved: 2026-10-06T13:50:27.250Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T16:08:35.622Z.
Quote observation: 2026-10-06T15:59:34.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f522eee919378f7ead273ce64f9b652ac6d8ba1380de8c5eb79fdcf7ed4dc2a
Forward PE Ratio (N/A) = Dated Quote Price ($0.60) / Consensus Forward EPS ($-0.51)
FORWARD PE RATIO
N/A
MDxHealth S.A.
Market Cap
$30.82M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| MDxHealth S.A. (MDXH) | $30.82M | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.90M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.20M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $29.91M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.82M | N/A |
| OneMedNet Corporation (ONMD)vs › | $29.67M | N/A |
| CervoMed Inc. (CRVO)vs › | $29.64M | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.14M | 9.52 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.60, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.51 | $-0.52 – $-0.49 | 3 | n/m |
| 2027-12-31 | $-0.28 | $-0.35 – $-0.21 | 3 | n/m |
| 2028-12-31 | $-0.15 | $-0.29 – $-0.03 | 3 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
